Arthrocentesis Followed by Autologous Blood Injection in the Treatment of Chronic Symptomatic Subluxation of Temporomandibular Joint

Sharma, Vikash; Anchlia, Sonal; Sadhwani, Bipin S; Bhatt, Utsav; Rajpoot, Dewanshi

doi:10.1007/s12663-021-01540-1

Cited by 4 publications

(5 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…TMDs that cause articular pain and mandibular mobility limitation are two main sons for delivering intra-articular injections, except for HD and AB administrations w are performed to treat recurrent subluxation of the temporomandibular [22,24,37,40,44,53,55,57,61,65,66,69,72,73,90,94,96,97,110,111,131,149,160,165,168]. rently, there is an intensive search for the gold standard of TMDs treatment, which i ficult due to the variety of etiologies and the specificity of individual dysfunctions main directions of research on the use of intra-articular injections in this indicatio presented below.…”

Section: Discussionmentioning

confidence: 99%

“…Autologous blood (AB) is the second, next to HD, substance administered into the TMJs for the treatment of hypermobility. Reports since 2017 describing AB therapy are fewer and generally with a lower level of evidence than these regarding HD (four randomized, one non-randomized, and six uncontrolled) [37,40,44,55,57,61,65,66,69,90]. The only included systematic review on AB therapy administrated intra-articularly suggests the need for randomized trials [168].…”

Section: Blood Preparations Autotransplantationmentioning

confidence: 99%

See 1 more Smart Citation

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Chęciński¹,

Chęcińska

Turosz

et al. 2023

JCM

View full text Add to dashboard Cite

This mapping review aims to identify and discuss current research directions on intracavitary temporomandibular joints (TMJs) injections. The inclusion criteria allowed studies published in the last full six years, based on patients diagnosed with temporomandibular joint disorders (TMDs), treated by TMJ intra-articular injections. Medical databases covered by the Association for Computing Machinery, Bielefeld Academic Search Engine, PubMed, and Elsevier Scopus engines were searched. The results were visualized with tables, charts, and diagrams. Of the 2712 records identified following the selection process, 152 reports were qualified for review. From January 2017, viscosupplementation with hyaluronic acid (HA) was the best-documented injectable administered into TMJ cavities. However, a significant growing trend was observed in the number of primary studies on centrifuged blood preparations administrations that surpassed the previously leading HA from 2021.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Blood Preparations Autotransplantationmentioning

confidence: 99%

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Chęciński¹,

Chęcińska

Turosz

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

“…It is assumed that the limitation of mobility in the TMJ is achieved due to fibrosis, which was found in an animal model [13][14][15]. The lack of the articular surfaces' cartilage disruption and leaving the articular disc intact presumably protect against ankylosis [12]. Moreover, in the course of AB therapy, the immobilization of the TMJs is partial and short-term or not implemented at all [7,9,[42][43][44]49,51,52,55,56].…”

Section: Discussionmentioning

confidence: 99%

“…Such protocols consist of intra-and peri-articular injection of hypertonic dextrose or autologous blood (AB) into and around the TMJs cavities [7][8][9]. The latter method of treatment creates conditions within the joint similar to blood extravasation, albeit without injury [12]. This leads to a reduction in the range of motion of the mandible, but not to ankylosis [1,[13][14][15].…”

Section: Introduction 1backgroundmentioning

confidence: 99%

Autologous Blood Injections in Temporomandibular Hypermobility: A Systematic Review

Chęciński,

Chęcińska,

Rąpalska

et al. 2023

JCM

View full text Add to dashboard Cite

The injection of autologous blood (AB) is one of the methods of treatment of recurrent dislocations in the temporomandibular joints (TMJs). Due to the low invasiveness of this technique, it is reasonable to evaluate it in accordance with the standards of evidence-based medicine. The purpose of this systematic review is to identify primary studies on AB injection for the treatment of TMJ hypermobility and assess the therapy for effectiveness. This systematic review was conducted in accordance with the current “Preferred Reporting Items for Systematic Reviews and Meta-Analyses” guidelines. Controlled randomized trials comparing dislocation episode rates, range of motion in the TMJ, or articular pain intensity were adopted as the eligibility criteria. Final searches were conducted on 11 June 2023 using Bielefeld Academic Search Engine, Elsevier Scopus, and the National Library of Medicine: PubMed. Trials were assessed using the “Oxford Center for Evidence-Based Medicine 2011 Levels of Evidence” scale and “A revised Cochrane risk-of-bias tool for randomized trials”. The results of the individual studies were tabulated, syntheses were illustrated in graphs. Twenty two studies involving 982 patients were included in the qualitative analysis, of which seven studies involving 390 patients were subject to quantitative analysis. None of the included randomized controlled trials presented a high risk of bias, 75% of them raised some concerns. In a three-month observation, administration of AB was more efficient in limiting temporomandibular dislocations than hypertonic dextrose (1 study, 32 patients, relative risk = 0.33, odds ratio = 0.29) and no difference in outcomes was observed between intracavitary and pericapsular administration compared to pericapsular injection alone (2 studies, 70 patients, relative risk = 1.00, odds ratio = 1.00). Injections of AB into the temporomandibular joints are effective in preventing further TMJ dislocation episodes in 75–94% of patients. This study received no funding.

show abstract

“…Studies on ABI indicate that it is effective, although it will occasionally require multiple injections [ 103 , 104 , 105 ], and has good long-term success [ 106 ]. It appears to be more effective when injected in the pericapsular tissues and not just the superior joint space alone [ 107 , 108 ], and the technique may be combined successfully with arthrocentesis or arthroscopy [ 109 , 110 ]. The European Society of TMJ Surgeons (ESTMJS) has recently published a consensus on the treatment of condylar dislocation, finding the best level of evidence for the use of autologous blood as a minimally invasive technique [ 98 ].…”

Section: Technical Advances In Tmj Surgerymentioning

confidence: 99%

Recent Advances in Temporomandibular Joint Surgery

Wroclawski,

Mediratta,

Fillmore

2023

Medicina

View full text Add to dashboard Cite

Temporomandibular disorders (TMDs) affect a high percentage of children and adults worldwide. Surgery may be indicated in severe or recalcitrant cases. Several recent advancements in TMD and temporomandibular joint (TMJ) surgery have elevated understanding and the ability to treat affected patients. We discuss recent advances in TMD epidemiology, juvenile idiopathic arthritis (JIA) of the TMJ, and surgical techniques and technologies. Technical advancements have been identified in TMJ arthroscopy, the treatment of TMJ subluxation and dislocation, and extended prosthetic total TMJ reconstruction (eTMJR). Overall, this review provides valuable insights into significant recent advancements in TMJ disorders and their surgical management.

show abstract

Arthrocentesis Followed by Autologous Blood Injection in the Treatment of Chronic Symptomatic Subluxation of Temporomandibular Joint

Cited by 4 publications

References 24 publications

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Current Clinical Research Directions on Temporomandibular Joint Intra-Articular Injections: A Mapping Review

Autologous Blood Injections in Temporomandibular Hypermobility: A Systematic Review

Recent Advances in Temporomandibular Joint Surgery

Contact Info

Product

Resources

About